| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.26 | 0.008 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.008 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.008 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.009 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.084 | 0.009 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.11 | 0.009 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | 0.088 | 0.009 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.077 | 0.01 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.01 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |